Kirk Siderman-Wolter
Directeur/Membre du Conseil chez Assurednano Ltd.
Profil
Kirk Siderman-Wolter is currently a Director at Assurednano Ltd.
and KSW Consultancy Ltd.
He previously worked as Finance Director & Director at Centre for Process Innovation Ltd., Director-Finance & Director at Nuformix Technologies Ltd., CFO & Senior Independent Non-Executive Director at Nuformix Plc, and Director at CFTBE Services Ltd., Consortium For The Built Environment Ltd., Lawns Blackheath Management Ltd., Together Southwark, and PolyPhotonix Ltd.
Mr. Siderman-Wolter holds an MBA degree from London Business School.
Postes actifs de Kirk Siderman-Wolter
| Sociétés | Poste | Début |
|---|---|---|
| Assurednano Ltd. | Directeur/Membre du Conseil | - |
| KSW Consultancy Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kirk Siderman-Wolter
| Sociétés | Poste | Fin |
|---|---|---|
| NUFORMIX PLC | Directeur Financier/CFO | 10/09/2019 |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur Financier/CFO | 09/09/2019 |
Centre for Process Innovation Ltd.
 Centre for Process Innovation Ltd. Investment ManagersFinance Centre for Process Innovation Ltd (CPI) is a venture capital firm founded in 2019. The firm is headquartered in Redcar, United Kingdom. | Directeur Financier/CFO | - |
PolyPhotonix Ltd.
 PolyPhotonix Ltd. Medical SpecialtiesHealth Technology PolyPhotonix Ltd. is a bio-photonic research and British development company that specializes in designing, developing, and manufacturing noninvasive photonic-based medical devices. The company is based in Sedgefield, UK. The company's focus is on light therapy treatments for macular eye disease. PolyPhotonix's most notable product is the Noctura 400 sleep mask, which is an innovative, noninvasive, and monitored home care treatment developed to prevent and treat diabetic retinopathy. The company was founded in 2008 by Richard Kirk, who has been the CEO since its inception. | Directeur/Membre du Conseil | - |
| Together Southwark | Directeur/Membre du Conseil | - |
Formation de Kirk Siderman-Wolter
| London Business School | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Entreprise privées | 9 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Assurednano Ltd. | |
| KSW Consultancy Ltd. | |
| Consortium For The Built Environment Ltd. | |
| CFTBE Services Ltd. | |
| Lawns Blackheath Management Ltd. | |
| Together Southwark | |
PolyPhotonix Ltd.
PolyPhotonix Ltd. Medical SpecialtiesHealth Technology PolyPhotonix Ltd. is a bio-photonic research and British development company that specializes in designing, developing, and manufacturing noninvasive photonic-based medical devices. The company is based in Sedgefield, UK. The company's focus is on light therapy treatments for macular eye disease. PolyPhotonix's most notable product is the Noctura 400 sleep mask, which is an innovative, noninvasive, and monitored home care treatment developed to prevent and treat diabetic retinopathy. The company was founded in 2008 by Richard Kirk, who has been the CEO since its inception. | Health Technology |
Centre for Process Innovation Ltd.
Centre for Process Innovation Ltd. Investment ManagersFinance Centre for Process Innovation Ltd (CPI) is a venture capital firm founded in 2019. The firm is headquartered in Redcar, United Kingdom. | Finance |
